Moyamoya angiopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:477768
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Moyamoya angiopathy (also called Moyamoya disease or Moyamoya syndrome) is a rare condition that affects the blood vessels in the brain. The name 'Moyamoya' comes from a Japanese word meaning 'puff of smoke,' which describes how the tiny, fragile blood vessels that form in the brain look on imaging scans. In this condition, the main arteries that supply blood to the brain slowly narrow and eventually become blocked. To try to compensate, the brain grows many small, abnormal blood vessels to keep blood flowing — but these vessels are fragile and do not work well. The disease can cause two main types of problems: strokes (when blood flow is blocked) and bleeding in the brain (when the fragile vessels burst). Symptoms depend on which part of the brain is affected and can include weakness on one side of the body, trouble speaking, vision problems, headaches, and seizures. In children, strokes are more common, while adults are more likely to experience bleeding in the brain. Treatment focuses on improving blood flow to the brain through surgery. The most common surgeries create new pathways for blood to reach the brain. There is no medication that stops the disease from progressing, but surgery can significantly reduce the risk of future strokes and improve quality of life. Early diagnosis and treatment are very important for the best outcomes.

Key symptoms:

Sudden weakness or numbness on one side of the bodyDifficulty speaking or understanding speechStroke or mini-stroke (TIA)Severe or recurring headachesSeizuresVision problems or sudden vision lossDifficulty with memory or thinkingInvoluntary movements (especially in children)Bleeding in the brain (more common in adults)Dizziness or loss of balanceFainting or loss of consciousnessDevelopmental delays or learning difficulties in childrenFatigue and reduced ability to concentrate

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Moyamoya angiopathy.

View clinical trials →

No actively recruiting trials found for Moyamoya angiopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Moyamoya angiopathy community →

No specialists are currently listed for Moyamoya angiopathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Moyamoya angiopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Moyamoya angiopathyForum →

No community posts yet. Be the first to share your experience with Moyamoya angiopathy.

Start the conversation →

Latest news about Moyamoya angiopathy

No recent news articles for Moyamoya angiopathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my Moyamoya disease, and how quickly is it likely to progress?,Am I a candidate for bypass surgery, and which type would be best for me?,Should I have genetic testing, and should my family members be screened?,What activities should I avoid to reduce my risk of having a stroke?,What are the warning signs that I should go to the emergency room immediately?,What rehabilitation services do you recommend, and how do I access them?,How often do I need follow-up imaging, and what are you looking for?

Common questions about Moyamoya angiopathy

What is Moyamoya angiopathy?

Moyamoya angiopathy (also called Moyamoya disease or Moyamoya syndrome) is a rare condition that affects the blood vessels in the brain. The name 'Moyamoya' comes from a Japanese word meaning 'puff of smoke,' which describes how the tiny, fragile blood vessels that form in the brain look on imaging scans. In this condition, the main arteries that supply blood to the brain slowly narrow and eventually become blocked. To try to compensate, the brain grows many small, abnormal blood vessels to keep blood flowing — but these vessels are fragile and do not work well. The disease can cause two main

How is Moyamoya angiopathy inherited?

Moyamoya angiopathy follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.